Q1 2025 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2025-05-15 · accession 0001856083-25-000002
$3.09B
Reported value
69
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $263.8M | 8.54% | 2,000,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $231.9M | 7.51% | 5,443,721 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $230.8M | 7.47% | 17,791,486 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $162.4M | 5.26% | 9,500,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $145.1M | 4.70% | 3,000,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $137.7M | 4.46% | 4,564,207 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $130.0M | 4.21% | 3,210,270 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $123.5M | 4.00% | 3,073,853 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $109.3M | 3.54% | 5,000,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $104.8M | 3.39% | 14,294,420 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $96.8M | 3.13% | 2,800,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $76.2M | 2.47% | 1,484,266 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $72.5M | 2.35% | 5,380,449 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $71.0M | 2.30% | 4,100,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $67.7M | 2.19% | 9,316,333 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $65.3M | 2.12% | 5,500,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $60.7M | 1.97% | 38,176,251 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $57.4M | 1.86% | 899,731 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $48.9M | 1.58% | 1,350,000 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $46.9M | 1.52% | 700,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $42.8M | 1.38% | 2,357,702 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $41.9M | 1.36% | 1,411,402 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $36.3M | 1.18% | 2,000,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $36.0M | 1.17% | 3,269,126 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $35.2M | 1.14% | 113,035 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $33.5M | 1.09% | 1,000,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $30.8M | 1.00% | 1,400,000 | Common | SOLE |
| 59267L107 | — | METSERA INC | $29.8M | 0.96% | 1,094,408 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $28.3M | 0.92% | 750,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $27.7M | 0.90% | 17,849,482 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $26.1M | 0.84% | 2,000,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $25.3M | 0.82% | 8,859,648 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $24.8M | 0.80% | 1,401,938 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $22.4M | 0.72% | 3,579,209 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $22.3M | 0.72% | 3,018,935 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $22.1M | 0.71% | 2,000,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $20.9M | 0.68% | 2,000,000 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $20.4M | 0.66% | 4,557,575 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $19.4M | 0.63% | 254,751 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $18.6M | 0.60% | 741,068 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $16.2M | 0.52% | 2,038,845 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $15.4M | 0.50% | 5,576,558 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $15.2M | 0.49% | 874,614 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $14.8M | 0.48% | 1,444,709 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $14.6M | 0.47% | 2,500,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $14.1M | 0.46% | 2,299,567 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $12.9M | 0.42% | 3,442,833 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $11.1M | 0.36% | 1,912,929 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $9.7M | 0.32% | 1,518,182 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $9.7M | 0.31% | 1,529,987 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $7.3M | 0.24% | 6,011,380 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $7.3M | 0.24% | 5,399,681 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $6.9M | 0.22% | 859,876 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $6.5M | 0.21% | 767,016 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $6.2M | 0.20% | 315,765 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $5.9M | 0.19% | 9,722,254 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $5.8M | 0.19% | 549,439 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $5.7M | 0.18% | 3,262,564 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $5.1M | 0.16% | 3,119,162 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $4.6M | 0.15% | 457,556 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $4.5M | 0.15% | 7,419,355 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $4.2M | 0.14% | 3,283,783 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $3.7M | 0.12% | 444,110 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $3.5M | 0.11% | 219,015 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $3.2M | 0.10% | 2,515,513 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $2.3M | 0.07% | 523,989 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.6M | 0.05% | 7,232,701 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $1.4M | 0.04% | 116,660 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $1.3M | 0.04% | 1,040,115 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.